TipRanks
Kinnevik AB (MX:KINVBN)
LSE:KINVBN
Mexico Market
EarningsQ2 2026 Earnings Report

Kinnevik AB (KINVBN) Q2 2026 Earnings Report

1 Followers

MX:KINVBN Q2 2026 EPS Results

Actual EPS$11.18
Consensus EPS―
Beat/Miss―
One Year Ago EPS$4.07

MX:KINVBN Q2 2026 Revenue Results

Actual Revenue$3.61M
Expected Revenue―
Beat/Miss―
YoY Revenue Growth0.00%

Earnings Announcement Details

QuarterQ2 2026
Date07/07/2026
TimeBefore Open
Conference CallTuesday, July 7, 2026
MX:KINVBN Upcoming Earnings
Kinnevik AB's next earnings date is estimated for October 15, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Jul 07, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasizes a clear progress narrative: NAV and portfolio value increased, margins improved, cash was preserved, cost-reduction measures and disciplined capital allocation were implemented, and selective follow-ons (e.g., Wordsmith) produced strong uplifts. Offsetting this are localized valuation write-downs (Climate Tech), recalibrations (Betterment), modest operational downgrades (Oviva, Mews), dilution from M&A (Spring+Alma) and one-off restructuring costs. Overall, positives around NAV growth, balance sheet strength, cost discipline and focused portfolio actions outweigh the contained negatives.
Company Guidance
The call’s guidance emphasized disciplined cost and capital management: a target to cut management cash costs to around SEK 200m pa (about a 30% reduction from SEK 313m in 2025) with measures largely implemented and further savings hitting in H2 (restructuring one‑offs mean 2026 costs will be similar to 2025); a cap on follow‑on investments of ~SEK 1.5bn to bring existing portfolio companies to profitability; Q2 net investments of SEK 57m (the lowest since Q4 2019) and participation in Wordsmith’s $70m round (Kinnevik SEK 29m; Wordsmith revenue up 14x YTD and >3x uplift vs entry); two agreed divestments (Oda ~SEK 100m, YouScan ~SEK 30m; ~SEK 133m proceeds expected in Q3) which would make the quarter net divestment SEK 76m adjusted; strong liquidity with cash at SEK 7.4bn (SEK 7.6bn adjusted) up SEK 75m vs Q1; and NAV/headline targets reflecting NAV SEK 29.6bn (SEK 107/share, +6% q/q, +5% cc) driven by portfolio value +8%, ~28% YTD growth in larger holdings, EBITDA margin improvement ~4 percentage points to -6%, Health & Bio +16% and Spring +29% in SEK fair value (combined $1bn revenue target next 12 months), though prior strategies were down 4% including a SEK 0.2bn Climate Tech write‑down.
Net Asset Value (NAV) Increase
NAV rose to SEK 29.6 billion (SEK 107 per share), an increase of ~6% in Q2 (5% in constant currencies); portfolio value grew by 8% in the quarter.
Strong YTD Growth in Larger Holdings
Larger portfolio holdings showed strong year-to-date growth of about 28% on average, contributing materially to NAV appreciation.
EBITDA Margin Improvement
Portfolio EBITDA margins improved by ~4 percentage points, moving to negative 6% (improvement from prior quarter).
Solid Cash Position and Liquidity
Cash remained effectively flat at SEK 7.4 billion (SEK 7.6 billion adjusted for agreed divestments), with net cash up SEK 75 million from Q1, preserving capital flexibility.
Capital Discipline and Low Net Investments
Net investments were SEK 57 million in Q2 — the lowest level since Q4 2019 — reflecting a highly disciplined approach to follow-on funding.
Cost Base Reduction and Target
Organization reduced headcount from ~45 (end-2025) to <25; target to reduce management cash costs to ~SEK 200 million/year by 2027 (~30% reduction vs SEK 313 million in 2025).
Successful Selective Follow-on: Wordsmith
Participated pro rata in Wordsmith’s $70m round with SEK 29m; Wordsmith revenue grew ~14x over last 12 months and round represents >3x uplift vs Kinnevik entry price.
Strategic Portfolio Actions and Exits
Agreed divestments in Oda (~SEK 100m) and YouScan (~SEK 30m) with expected proceeds SEK 133m to close in Q3, and 33% of private portfolio (by value) saw transactions in last 12 months at a 10% weighted avg premium to prior NAV marks.
Spring Health Operational Progress
Spring closed acquisition of Alma; combined company targets ~$1 billion revenue over next 12 months, gross margins in high-50s and continued EBITDA profitability; Spring fair value +29% in SEK during quarter.

MX:KINVBN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Oct 15, 2026
2026 (Q3)
- / -
4.823―
2026 (Q2)
- / 11.18
4.074174.29% (+7.10)
2026 (Q1)
- / -51.87
-19.759-162.52% (-32.11)
2025 (Q4)
- / -10.91
11.677-193.42% (-22.59)
2025 (Q3)
- / 4.82
-12.223139.45% (+17.05)
2025 (Q2)
- / 4.07
-1.235429.93% (+5.31)
2025 (Q1)
- / -19.76
-1.235-1500.00% (-18.52)
2024 (Q4)
- / 11.68
-16.811169.46% (+28.49)
2024 (Q3)
- / -12.22
-21.32442.68% (+9.10)
2024 (Q2)
- / -14.76
-7.384-99.90% (-7.38)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed